Secondary pharmacotherapeutic prevention among german primary care patients with peripheral arterial disease

International Journal of Vascular Medicine

Volumn 2011, Issue , 2011, Pages

  Müller Bühl, Uwe ^a   Laux, Gunter ^a   Szecsenyi, Joachim ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872647920     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2011/316496     Document Type: Article

References (28)

1. Khan S., Flather M., Mister R., Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry. European Journal of Vascular and Endovascular Surgery 2007 33 4 442 450 2-s2.0-33847407569 10.1016/j.ejvs.2006.11.010 (Pubitemid 46336595)
2. Hasimu B., Li J., Yu J., Evaluation of medical treatment for peripheral arterial disease in chinese high-risk patients. Circulation Journal 2007 71 1 95 99 2-s2.0-33846026053 10.1253/circj.71.95 (Pubitemid 46045557)
3. Bianchi C., Christian.Bianchi@va.gov Montalvo V., Ou H. W., Bishop V., Abou-Zamzam A. M. Jr., Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation. Annals of Vascular Surgery 2007 21 2 163 166 10.1016/j.avsg.2007.01.008 (Pubitemid 46367551)
4. Blacher J., Cacoub P., Luizy F., Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study. Journal of Vascular Surgery 2006 44 2 314 318 2-s2.0-33746741040 10.1016/j.jvs.2006.04.002 (Pubitemid 44160761)
5. Rehring T. F., Stolcpart R. S., Sandhoff B. G., Merenich J. A., Hollis H. W. Jr., Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease. Journal of Vascular Surgery 2006 43 6 1205 1210 2-s2.0-33744758006 10.1016/j.jvs.2006.02.019 (Pubitemid 43825671)
6. Zeymer U., Parhofer K. G., Pittrow D., Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort. Clinical Research in Cardiology 2009 98 4 249 256 2-s2.0-63449120072 10.1007/s00392-009-0754-1
7. Ness J., Aronow W. S., Newkirk E., McDanel D., Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic. Journals of Gerontology-Series A 2005 60 2 255 257 2-s2.0-17144379747 (Pubitemid 40524868)
8. Diehm C., Schuster A., Allenberg J. R., High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004 172 1 95 105 2-s2.0-9144228241 10.1016/S0021- 9150(03)00204-1 (Pubitemid 38058606)
9. Klein-Weigel P. F., Gutsche-Petrak B., Wolbergs S., Köning C., Flessenkamper I., Secondary medical prevention in patients with peripheral arterial disease-prescriptions of vascular surgeons and medical doctors (angiologists) in a multidisciplinary vascular centre. Vasa-Journal of Vascular Diseases 2010 39 2 145 152 2-s2.0-77952506263 10.1024/0301-1526/a000020
10. Laux G., Küehlein T., Rosemann T., Szecsenyi J., Co- and multimorbidity patterns in primary care based on episodes of care: results from the German CONTENT project. BMC Health Services Research 2008 8 1, article 14 2-s2.0-39149111204 10.1186/1472-6963-8-14 (Pubitemid 351257765)
11. ICPC-2-R: International Classification of Primary Care 2005 2nd Oxford, UK Oxford University Press
12. Rosenbaum P. R., Rubin D. B., The central role of the propensity score in observational studies for causal effects. Biometrika 1983 70 1 41 55 10.1093/biomet/70.1.41
13. The R project for statistical computing. 2009. http://www.r-project.org
14. Sekhon J. S., Multivariate and propensity score matching software with automated balance optimization: the matching package for R. Journal of Statistical Software. In press. http://ssrn.com/abstract=1009044
15. O'Halloran J., Miller G. C., Britt H., Defining chronic conditions for primary care with ICPC-2. Family Practice 2004 21 4 381 386 2-s2.0-4444273416 10.1093/fampra/cmh407 (Pubitemid 39162006)
16. The WHO Collaborating Centre for Drug Statistics Methodology,. http://www.whocc.no/atcddd
17. Gasse C., Jacobsen J., Larsen A. C., Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction. European Journal of Vascular and Endovascular Surgery 2008 35 1 51 58 2-s2.0-37049018610 10.1016/j.ejvs.2007.08.008 (Pubitemid 350245449)
18. Radack K., Deck C., Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease: a meta-analysis of randomized controlled trials. Archives of Internal Medicine 1991 151 9 1769 1776 2-s2.0-0025992650 10.1001/archinte.151.9.1769
19. Aronow W. S., Ahn C., Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease. American Journal of Cardiology 2001 87 11 1284 1286 2-s2.0-0035371384 10.1016/S0002-9149(01)01521-1 (Pubitemid 32493871)
20. Lane D. A., Lip G. Y., Treatment of hypertension in peripheral arterial disease. Cochrane Database of Systematic Reviews 2009 4, article CD003075 2-s2.0-75349084006
21. Lawall H., Diehm C., Pittrow P., Leitlinien zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK). Vasa-Journal of Vascular Diseases 2010 38 supplement 75 1 75
22. Pedersen T. R., Kjekshus J., Pyorala K., Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S). American Journal of Cardiology 1998 81 3 333 335 2-s2.0-0032006859 10.1016/S0002-9149(97)00904-1 (Pubitemid 28099310)
23. Heart Protection Study Collaborative Group, MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. The Lancet 2002 360 9326 7 22 10.1016/S0140-6736(02)09327-3 (Pubitemid 34756487)
24. Anand S. S., Kundi A., Eikelboom J., Yusuf S., Low rates of preventive practices in patients with peripheral vascular disease. Canadian Journal of Cardiology 1999 15 11 1259 1263 2-s2.0-0033404976 (Pubitemid 30006765)
25. Berger J. S., Krantz M. J., Kittelson J. M., Hiatt W. R., Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA-Journal of the American Medical Association 2009 301 18 1909 1919 2-s2.0-65549105821 10.1001/jama.2009.623
26. Cannon C. P., Rhee K. E., Califf R. M., Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for continued health [REACH] registry). American Journal of Cardiology 2010 105 4 445 452 2-s2.0-75349099088 10.1016/j.amjcard.2009.10.014
27. Hirsch A. T., Criqui M. H., Treat-Jacobson D., Peripheral arterial disease detection, awareness, and treatment in primary care. The Journal of the American Medical Association 2001 286 11 1317 1324 2-s2.0-0035913589 (Pubitemid 33015522)
28. McDermott M. M., Hahn E. A., Greenland P., Atherosclerotic risk factor reduction in peripheral arterial disease: results of a national physician survey. Journal of General Internal Medicine 2002 17 12 895 904 2-s2.0-18744363609 10.1046/j.1525-1497.2002.20307.x (Pubitemid 35471987)